Baptist Health

HealthSource of Ohio names Jody Prather, MD, as its President and CEO

Retrieved on: 
Tuesday, April 23, 2024
University, Baptists, Health, Marketing, Population health, Private practice, Commonwealth, MD, Centre College, Patient, Advertising, Baptist Health, McAndrew, Growth, Management

CINCINNATI, April 23, 2024 (GLOBE NEWSWIRE) -- HealthSource of Ohio announced today the appointment of Jody Prather, MD as its next President and Chief Executive Officer following an extensive, nationwide search process.

Key Points: 
  • CINCINNATI, April 23, 2024 (GLOBE NEWSWIRE) -- HealthSource of Ohio announced today the appointment of Jody Prather, MD as its next President and Chief Executive Officer following an extensive, nationwide search process.
  • Dr. Prather succeeds Kim Patton, who announced in May 2023 her intention to retire from HealthSource.
  • Dr. Prather will officially take over as CEO effective May 30, 2024.
  • “We are delighted to welcome Jody as our new President and Chief Executive Officer,” said Mark A. McAndrew, HealthSource Board Chair & Partner at Taft.

Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024

Retrieved on: 
Wednesday, April 24, 2024
Oncology, Health, FDA, Surgery, Clinical Trials, Pharmaceutical, Biotechnology, METIS, Efficacy, Safety, Patient, Deep learning, International, TIGER, Abstract, Survival, Metastasis, Lung cancer, MD, Baptist Health South Florida, Glioblastoma, ASCO, Radiation therapy, Pembrolizumab, Treatment, Brain, Society, Platinum, CDT, Clinical trial, Annual general meeting, Baptist Health, NSCLC, Medical imaging

METIS was a randomized phase 3 clinical trial of stereotactic radiosurgery with or without Tumor Treating Fields (TTFields) therapy for patients with 1-10 brain metastases from NSCLC.

Key Points: 
  • METIS was a randomized phase 3 clinical trial of stereotactic radiosurgery with or without Tumor Treating Fields (TTFields) therapy for patients with 1-10 brain metastases from NSCLC.
  • “We are honored to present the results of the METIS clinical trial as a late-breaking abstract this year at ASCO, the largest global oncology conference,” said Asaf Danziger, Novocure’s Chief Executive Officer.
  • “Patients with brain metastases from non-small cell lung cancer need more treatment options.
  • The METIS trial demonstrated that TTFields Therapy delayed intracranial progression while preserving neurological function, which is critical for these underserved patients.

Green Security Partners with Spire Capital and Strattam Capital

Retrieved on: 
Wednesday, April 24, 2024
Ochsner Health System, Mayo Clinic, Safety, Credentialing, Sutter Health, Partnership, Software as a service, Growth, Entrepreneurship, Partner (business rank), Accreditation, Patient, Face, Mass General Brigham, Security, Baptist Health, Cryptocurrency

CLEARWATER, Fla., April 24, 2024 /PRNewswire-PRWeb/ -- Green Security, a leading provider of SaaS healthcare compliance and access management solutions, announced a majority growth investment, led by Spire Capital and Strattam Capital.

Key Points: 
  • "This new investment will allow Green Security to expand to meet the growing customer demand for its innovative platform," said Sean White, Partner at Spire Capital.
  • "Securing this investment from our new private equity partners is not just a validation of our vision, but a catalyst for growth," said Shawn Fitzgibbons, Founder and CEO, Green Security.
  • "We could not be more excited to help bring the Green Security solution to a wider audience, to solve a growing range of challenges to facility security and access."
  • VedderPrice served as legal counsel to Spire Capital and TPG Twin Brook Capital Partners provided debt financing.

American Tinnitus Association Announces Patrick A. Lynch as New CEO

Retrieved on: 
Thursday, April 11, 2024
Leukemia & Lymphoma Society, Education, Rhode Island Bar Association, Hospice, Heart, Business administration, Research, American Tinnitus Association, Baptist Health South Florida, Tinnitus, TED (conference), Leukemia, Veteran, Suffolk University Law School, Big Brothers Big Sisters, MBA, ATA, Baptist Health, Growth

VIENNA, Va., April 11, 2024 /PRNewswire/ -- The American Tinnitus Association (ATA), the nation's only nonprofit dedicated exclusively to serving the tinnitus community, announced its hiring of Patrick A. Lynch, Esq., MBA, as its chief executive officer.

Key Points: 
  • VIENNA, Va., April 11, 2024 /PRNewswire/ -- The American Tinnitus Association (ATA), the nation's only nonprofit dedicated exclusively to serving the tinnitus community, announced its hiring of Patrick A. Lynch, Esq., MBA, as its chief executive officer.
  • With a lifelong commitment to community engagement and an exceptional track record in advocacy, fundraising, and nonprofit leadership, Lynch brings unparalleled expertise to ATA.
  • "It is an incredible honor to join the team at the American Tinnitus Association," said Lynch.
  • "More than 50 million people in the United States are affected directly by tinnitus, including 30 percent of all U.S. veterans.

Humantelligence joins Engage, backed by Tech Square Ventures, to Bring Innovation to Southeast-based Enterprises

Retrieved on: 
Thursday, April 11, 2024
Goldman Sachs, The Coca-Cola Company, The Home Depot, HR, BASF, GTM, Communication, Georgia-Pacific, Delta Air Lines, Running, UnitedHealth Group, Baptist Health, Georgia Tech, Friction, Organization, Honeywell, Management

ATLANTA, April 11, 2024 /PRNewswire-PRWeb/ -- Humantelligence, a leading HR and collaboration technology leader, announced that it is joining Atlanta-based Engage, the collaborative innovation and corporate venture platform.

Key Points: 
  • -Bill Nussey, Partner, Tech Square Ventures/Engage
    Engage is designed for high-growth start-ups and provides capital, mentorship and access to category-leading corporations.
  • Humantelligence joins the Engage Enterprise Go-to-Market program, which streamlines the process of working with the most influential corporations in the world.
  • Tech Square Ventures' Engage is backed by 16 industry-leading enterprises, including The Coca-Cola Company, Delta Air Lines, Georgia-Pacific, Georgia Power Foundation, Georgia Tech, Goldman Sachs, The Home Depot, and Honeywell, among others.
  • "We are thrilled to bring Humantelligence into our program," said Bill Nussey, Partner, Tech Square Ventures/Engage.

Baptist Health Foundation Announces Historic $50 Million Gift from Kenneth C. Griffin

Retrieved on: 
Tuesday, March 19, 2024
Citadel, Epilepsy, Baptist Health, Neurology, Baptist Health South Florida, Science, Alzheimer's disease, Incidence, Patient, Research, History, Neuroscience, Parkinson's disease, Baptists, DSM-IV codes, Hospital, Baptist Hospital, Physician, Health, Dementia, Medicine, Pharmaceutical industry

Miami, FL, March 19, 2024 (GLOBE NEWSWIRE) -- Baptist Health Foundation today announced the largest single donation in the nearly 65-year history of Baptist Health South Florida.

Key Points: 
  • Miami, FL, March 19, 2024 (GLOBE NEWSWIRE) -- Baptist Health Foundation today announced the largest single donation in the nearly 65-year history of Baptist Health South Florida.
  • The $50 million gift from Kenneth C. Griffin, founder and CEO of Miami-based hedge fund Citadel and founder of Griffin Catalyst, will advance neurological care in the region.
  • The new Kenneth C. Griffin Center at Miami Neuroscience Institute will also help advance research related to neuroscience and neurodegenerative disorders.
  • “This extraordinary gift is a visionary contribution to the well-being of current and future generations in South Florida and beyond,” said Bo Boulenger, president and CEO of Baptist Health.

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

Retrieved on: 
Wednesday, March 27, 2024
Neurology, Radiology, Biotechnology, Pharmaceutical, Oncology, General Health, Health, Clinical Trials, EST, Baptist Health, METIS, Baptist Health South Florida, NSCLC, Webcast, Patient, Radiosurgery, Brain, Regulation, SRS, Disclosure, MD, Quality of life, Lung cancer, Congress, Regulation Fair Disclosure, Clinical trial, Cognition, Radiation therapy, Medical imaging

Patients treated with TTFields therapy and supportive care exhibited a median time to intracranial progression of 21.9 months compared to 11.3 months in patients treated with supportive care alone for brain metastasis (n=298; hazard ratio=0.67; P=0.016).

Key Points: 
  • Patients treated with TTFields therapy and supportive care exhibited a median time to intracranial progression of 21.9 months compared to 11.3 months in patients treated with supportive care alone for brain metastasis (n=298; hazard ratio=0.67; P=0.016).
  • Median TTFields therapy treatment duration was 16 weeks and median usage was 67%.
  • Consistent with previous studies, TTFields therapy was well-tolerated with sustained quality of life and neurocognitive function.
  • Certain secondary endpoints showed positive trends in favor of treatment with TTFields therapy, including time to distant progression and quality of life.

Comcast Completes $46M in Technology Infrastructure Projects Across Florida’s First Coast

Retrieved on: 
Monday, March 11, 2024
Telecommunications, Networks, Internet, TV and Radio, Media, Communications, Technology, Entertainment, Storm, Baptist Health, Xfinity, Learning, Caregiver, Fountain, Patient, Comcast Business, Economic development, Videotelephony, Enterprise, Roger Hawkins (drummer), Quality of life, Wi-Fi, Baptists, Senior, Investment, Digital divide, Video, Data-rate units, Florida State Road 23

“Jacksonville is a dynamic, growing market,” said Comcast’s Florida Region Senior Vice President, Jeff Buzzelli.

Key Points: 
  • “Jacksonville is a dynamic, growing market,” said Comcast’s Florida Region Senior Vice President, Jeff Buzzelli.
  • “With more than 500 employees, more than 13,000 miles of network infrastructure and hundreds of thousands of customers, Comcast is part of the fabric of Jacksonville and the surrounding area.
  • We’re so happy Comcast is giving back to the community right here in Jacksonville by investing in our organization.
  • Most Reliable Connection: Comcast is scaling the nation’s largest and most reliable network that passes 62 million homes and business and counting.

Tecsys Named a Major Player in the 2024 IDC MarketScape for Worldwide Warehouse Management

Retrieved on: 
Tuesday, April 2, 2024
Organization, Baptist Health, Forecasting, Risk, TCS, Transport, IDC, AI, Architecture, TSX, Inventory, WMS

MONTREAL, April 2, 2024 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), a global leader in supply chain management solutions, has been positioned in the Major Players Category in the IDC MarketScape: Worldwide Warehouse Management 2024 Vendor Assessment (Doc #US49948523, March 2024).

Key Points: 
  • MONTREAL, April 2, 2024 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), a global leader in supply chain management solutions, has been positioned in the Major Players Category in the IDC MarketScape: Worldwide Warehouse Management 2024 Vendor Assessment (Doc #US49948523, March 2024).
  • This inaugural IDC MarketScape assessment evaluates ten WMS vendors, positioning them in one of four categories based on their strategies and capabilities.
  • Elite™ WMS is a cornerstone of Tecsys' broader suite of solutions built on a digitally enabled, integrated platform designed to simplify complex supply chain operations.
  • "In recognition of our position as a Major Player in the IDC MarketScape for Worldwide Warehouse Management, we're inspired to continue pushing the boundaries of what's possible in supply chain management," remarked Peter Brereton, president and CEO of Tecsys.

Freshpaint Meets Latest Federal Guidance for Replacing Tracking Technologies with its Healthcare Privacy Platform

Retrieved on: 
Wednesday, March 20, 2024
Organization, Baptist Health, Health, SAN, Health care, HHS, Google Maps, HIPAA, ID, Privacy, Marketing, Pharmaceutical industry

SAN FRANCISCO, March 20, 2024 /PRNewswire-PRWeb/ -- Today, Freshpaint announced that its Healthcare Privacy Platform meets the latest federal guidance dictating how healthcare companies should use the industry's best marketing, analytics, and advertising tools while remaining HIPAA compliant.

Key Points: 
  • Today, Freshpaint announced that its Healthcare Privacy Platform meets the latest federal guidance dictating how healthcare companies should use the industry's best marketing, analytics, and advertising tools while remaining HIPAA compliant.
  • SAN FRANCISCO, March 20, 2024 /PRNewswire-PRWeb/ -- Today, Freshpaint announced that its Healthcare Privacy Platform meets the latest federal guidance dictating how healthcare companies should use the industry's best marketing, analytics, and advertising tools while remaining HIPAA compliant.
  • Since its introduction, hundreds of healthcare organizations, including vybe urgent care and Baptist Health, have adopted Freshpaint's Healthcare Privacy Platform to maintain a balance between HIPAA compliance and high-performance marketing.
  • For more information about how Freshpaint's Healthcare Privacy Platform meets the latest federal guidance, visit https://www.freshpaint.io/blog/hhs-approves-tools-like-freshpaint .